Primary aortic valve replacement with cryopreserved aortic allograft - An echocardiographic follow-up study of 570 patients

Article

关键词: ENDOCARDITIS;    HOMOGRAFTS;    ROOT;    AREA;    REGURGITATION;    IMPLANTATION;    EXPERIENCE;    FREEHAND;   

DOI  :  10.1161/hc0102.101357

来源: SCIE

【 摘 要 】

Background-Despite the many advantages of an aortic allograft valve (AAV) over a prosthetic aortic valve, its durability is suboptimal. The aims of the present study were to document characteristic features of AAV dysfunction and to investigate factors influencing the development of such dysfunction. Methods and Results-A group of 570 patients (mean age, 48 +/- 16 years) with a cryopreserved AAV underwent a follow-up echocardiographic study (mean time after surgery, 6.8 years; range, 1.0 to 22.9 years). Significant AAV regurgitation was present in 14.7% of patients, and AAV stenosis was present in 3.2%. The root replacement subgroup had the smallest number of patients with significant AAV regurgitation (5.0%) compared with the subcoronary (23.0%) or the inclusion cylinder technique subgroup (14.7%). After 10 to 15 years after AAV replacement, grade 2 AAV dysfunction was present in 40% of patients in the subcoronary subgroup, but no significant dysfunction was observed in patients in the root replacement subgroup (P<0.001). Smaller host aortic annulus size in both subcoronary (coefficient, -0.145, P=0.013) and root replacement subgroups (coefficient, -0.249; P=0.011) was associated with more frequent AAV dysfunction (grade greater than or equal to 2). In addition, significant AAV dysfunction was more frequent when patients were younger (coefficient, - 0.020; P=0.015) in the subcoronary subgroup and the donor was older (coefficient, 0.054; P=0.019) in the root replacement subgroup. Conclusions-The present study indicates that the root replacement technique is associated with less frequent AAV degeneration. Our findings should help in establishing more strict selection criteria for surgical replacement procedure type and patient/donor factors for AAV replacement and, therefore, could lead to improve AAV longevity.

【 授权许可】

Free